MedTrace Logo

Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil

NCT03622047 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1800

Last updated 2020-02-05

No results posted yet for this study

Summary

The participants: 1800 full-term primiparas will be selected with ASA I-Ⅱgrade, 20 to 35 years old and weighing 55 to 90 kg in the investigator's hospital from may 2018 to December 2018. 1200 primiparas were divided into A and B according to the computer randomized numbers, and 600 parturients without labor analgesia in the same period were selected as group C, with 600 patients in each group. All parturients signed the informed consent form and were approved by the hospital ethics Committee.

Conditions

  • Pharmacological Action

Interventions

DRUG

Dexmedetomidine ropivacaine

Observing the effect of 0.5 μ g / ml sufentanil+ 0.1 % ropivacaine with 2 hours after fetal delivery, and the patients leave the delivery room without abnormality.

DRUG

No analgesia labor

No analgesia labor control group

Sponsors & Collaborators

  • Women and children's hospital of Jiaxing university

    collaborator UNKNOWN

  • Shanghai First Maternity and Infant Hospital

    collaborator OTHER

  • Fudan University

    lead OTHER

Principal Investigators

  • Yongtao Gao, MD · Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2020-08-01
Completion
2020-08-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03622047 on ClinicalTrials.gov